Enanta Pharmaceuticals, Inc. (ENTA)

NASDAQ: ENTA · Real-Time Price · USD

10.50

-0.01 (-0.10%)

At close: Oct 27, 2025, 4:00 PM EDT

10.30

-0.20 (-1.90%)

After-hours: Oct 27, 2025, 4:13 PM EDT

Revenue by Product

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2008 - 2019
Period Ending	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	2008 - 2019
Small Molecule Drugs	67.64M	Log In	Log In	Log In	Log In	Upgrade
Small Molecule Drugs Growth	-14.61%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2008 - 2019
Period Ending	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	2008 - 2019
United States	67.64M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-14.61%	Log In	Log In	Log In	Log In	Upgrade